Sort
51,593 grants matching “hepatitis”
Hepatitis C Pathogenesis & The Human Genome
$649,570David L Thomas · Johns Hopkins University · R01 · FY2006 · DA
Probing the specificity and activity of the metazoan Integrator complex
$649,491Karen L Adelman · Harvard Medical School · R01 · FY2022 · GM
Effect of Time-Restricted Feeding on 24-hour Glycemic Control, Blood Pressure, and Cardiovascular Disease Risk Factors in Adults with Prediabetes
$649,428Courtney Marie Peterson · University Of Alabama At Birmingham · R01 · FY2022 · DK
Improving Outcome in Patients with Advanced Intrahepatic Cholangiocarcinoma: A Randomized Phase II Study of Gemcitabine and Oxaliplatin With or Without Regional Floxuridine (FUDR)
$649,386William Robert Jarnagin · Sloan-Kettering Inst Can Research · U01 · FY2022 · CA
EVALUATING SUPERVISED HAART IN LATE STAGE HIV IN IDUS
$649,374New York Academy Of Medicine · R01 · FY2001 · DA
Genetic Modifiers of Liver Disease Severity in Alagille Syndrome
$649,374Nancy Bettina Spinner · Children'S Hosp Of Philadelphia · R01 · FY2012 · DK
1/2 Alcohol Associated Comorbidities and Microbiome Evaluation in HIV (ACME HIV)
$649,329Matthew S Freiberg · Vanderbilt University Medical Center · U01 · FY2019 · AA
Analysis of Chemical Structures and Therapeutic Activity of Agents for HIV, TB, and HBV (CHEMDB)
$649,242Louise Sumner · Gryphon Scientific, Llc · N01 · FY2021 · AI
Creation of in vivo active chemical probes for CAMKK2 to treat cancer
$649,225David Harold Drewry · Univ Of North Carolina Chapel Hill · R01 · FY2018 · CA
Regulation of Hepatic Gluconeogenesis by the CREB:TORC2 Pathway
$649,117Marc R Montminy · Salk Institute For Biological Studies · R37 · FY2013 · DK
Macrophage-targeting Nanoplatforms as Immunotherapy against Pulmonary Infections
$649,115Michael J Sailor · University Of California, San Diego · R01 · FY2025 · AI
Immune correlates of acute HBV recovery with and without HIV
$649,053Chloe L Thio · Johns Hopkins University · R01 · FY2017 · AI
Zinc for HIV Disease among Alcohol Users -An RCT in the Russia ARCH Cohort
$649,044Jeffrey H Samet · Boston Medical Center · U01 · FY2016 · AA
XO INHIBITOR FOR THERAPY OF ACETAMINOPHEN INTOXICATION
$648,904Inotek Pharmaceuticals Corporation · R44 · FY2001 · GM
Interactions between neutrophils and cholangiocytes in alcoholic hepatitis
$648,806Michael H Nathanson · Yale University · R01 · FY2023 · AA
The UCLA Center in Early Detection of Liver Cancer
$648,658Xianghong Jasmine Zhou · University Of California Los Angeles · U01 · FY2019 · CA
Decoding the MST1 and MST2 kinases in cellular physiology and tumor suppression
$648,642Joseph Avruch · Massachusetts General Hospital · R01 · FY2011 · CA
Developmental Core
$648,571Herman F. Staats · Duke University · P30 · FY2024 · AI
T cells in HCV/HIV co-infection
$648,499Georg Michael Lauer · Massachusetts General Hospital · R01 · FY2021 · DA
T cells in HCV/HIV co-infection
$648,499Georg Michael Lauer · Massachusetts General Hospital · R01 · FY2019 · DA
T cells in HCV/HIV co-infection
$648,499Georg Michael Lauer · Massachusetts General Hospital · R01 · FY2018 · DA
T cells in HCV/HIV co-infection
$648,499Georg Michael Lauer · Massachusetts General Hospital · R01 · FY2022 · DA
T cells in HCV/HIV co-infection
$648,499Georg Michael Lauer · Massachusetts General Hospital · R01 · FY2020 · DA
A118G SNP and OPRM1 Gene Opioid-Mediated Effects in Humans
$648,482Kelly E Dunn · Johns Hopkins University · R01 · FY2016 · DA
Obesity risk in African American women is determined by a diet-by-phenotype interaction
$648,373Barbara A. Gower · University Of Alabama At Birmingham · R01 · FY2020 · DK